Is an additional post-myocardial infarction beta-blocker trial required in the era of early revascularization?
Mickley
Hans
H
Eiskjaer
Hans
H
Bøtker
Hans Erik
HE
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
D000319:Adrenergic beta-Antagonists